As of 2026-04-20, the Relative Valuation of Paratek Pharmaceuticals Inc (PRTK) is (17.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on Relative Valuation is -877.9%.
The range of the Relative Valuation is (12.15) - (18.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.1x - 18.5x | 16.8x |
| Forward P/E multiples | 10.2x - 16.9x | 15.0x |
| Fair Price | (12.15) - (18.52) | (17.35) |
| Upside | -644.8% - -930.4% | -877.9% |
| Date | P/E |